A look at fundamentally strong largecap stocks bought by DIIs.
A hidden data centre play at Palava could transform Lodha Developers’ growth story, with Jefferies seeing massive upside ahead.
Emkay Global retains Buy on KPIL with a target of Rs 1,450, citing strong T&D growth drivers; discover if this…
India approves Rs 2.38 trillion defence deals, spotlighting BEL, HAL, L&T, and GRSE—track these stocks for future order wins!
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…
Strong BEL order inflows impress Street, but rich valuations keep upside limited as Nomura stays cautious.
Pharma stocks fall as Nifty Pharma drops 3%. Sun Pharma, Cipla slide amid US tariff fears and export risk concerns.
Anaemia isn’t just about iron deficiency. Learn about the roles of Vitamin B12, chronic illness, and gut health in blood…
Superhealth’s model centres on building lower-cost hospitals while eliminating procedure-linked commissions. Instead of purchasing land, the company signs long-term leases…
Indian stock markets plunged as crude oil prices spiked and West Asia tensions escalated. Sensex fell 1,352 points while Nifty…
Markets watchlist today, March 02: Nifty slips below 200-DMA as banks drag index lower; track key levels and market trends…
Nifty IT plunges 12%, raising downtrend fears as attention shifts to Divi’s Lab, Apollo Hospitals, and 7 key stocks; check…
Explore 10 top stock picks with up to 42% upside potential—see which brokerages recommend buying now.
Explore Nuvama’s top 3 ‘Buy’ stock picks with up to 56% upside in infrastructure, healthcare, and consumer durables — read…
Gold and Silver ETFs slipped sharply on February 12 as MCX and COMEX futures weakened. Here’s the key global trigger…
Titan’s December quarter turned blockbuster as wedding demand and gold buying defied high prices, prompting top brokerages to project up…
Brokerage major Nuvama turns bullish on five pharma and healthcare stocks, citing semaglutide launches, CGHS rate revisions, capacity expansion and…
Eicher jumps 6%, M&M profit surges 47% while Aurobindo slides 8% as Q3 earnings drive sharp stock moves.